Tech Company Financing Transactions
ProciseDx Funding Round
ProciseDx closed a $10.5 million funding round on 7/22/2020. Backers included Biosynex and private investors.
Transaction Overview
Company Name
Announced On
7/22/2020
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$10,500,000
Round
Undisclosed
Investors
Biosynex (Lead Investor) (Larry Abensur)
Proceeds Purpose
Strategic transaction that will help us generate immediate revenues, scale up instrument production, launch our products internationally and fund our US clinical trials.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
9449 Carroll Park Dr.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Undisclosed
Website
Email Address
Overview
ProciseDx is a diagnostics company committed to the development and commercialization of a broad portfolio of point-of-care diagnostic tests for use in physician offices, retail clinics and urgent care. ProciseDx currently has 25 employees, 30,000 sq. ft. of laboratory, manufacturing and office space and is ISO13485 certified.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Larry Mimms
President
Peter Westlake
VP - Marketing
David Moore
VP - Product Management
Valerie Day
VP - R & D
Michael Hale
VP - Regulatory Affairs
Daniel Kiser
Browse more venture capital transactions:
Prev: 7/22/2020: Propeller Mapping venture capital transaction
Next: 7/22/2020: SmartHop venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs